Source:http://linkedlifedata.com/resource/pubmed/id/18991850
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2008-11-10
|
pubmed:abstractText |
A recent study showed a significant association between schizophrenia in European samples and the glutamate cysteine ligase modifier (GCLM) subunit gene, which is the key glutathione (GSH)-synthesizing enzyme. Since the symptoms of methamphetamine (METH)-induced psychosis are similar to those of schizophrenia, the GCLM gene is thought to be a good candidate gene for METH-use disorder or related disorders. To evaluate the association between the GCLM gene and METH-use disorder and schizophrenia, we conducted a case-control study of Japanese subjects (METH-use disorder, 185 cases; schizophrenia, 742 cases; and controls, 819). Four SNPs (2 SNPs from an original report and JSNP database, and 2 "tagging SNPs" from HapMap database) in the GCLM gene were examined in this association analysis; one SNP showed an association with both METH-use disorder and METH-induced psychosis. After Bonferroni's correction for multiple testing, however, this significance disappeared. No significant association was found with schizophrenia. Our findings suggest that a common genetic variation in the GCLM gene might not contribute to the risk of METH-use disorder and schizophrenia in the Japanese population.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1749-6632
|
pubmed:author |
pubmed-author:HaranoMutsuoM,
pubmed-author:HoriToruT,
pubmed-author:IkedaMasashiM,
pubmed-author:InadaToshiyaT,
pubmed-author:IwataNakaoN,
pubmed-author:IyoMasaomiM,
pubmed-author:KawashimaKunihiroK,
pubmed-author:KinoshitaYokoY,
pubmed-author:KishiTaroT,
pubmed-author:KitajimaTsuyoshiT,
pubmed-author:KomiyamaTokutaroT,
pubmed-author:OzakiNorioN,
pubmed-author:SekineYoshimotoY,
pubmed-author:SoraIchiroI,
pubmed-author:UjikeHiroshiH,
pubmed-author:YamadaMitsuhikoM,
pubmed-author:YamanouchiYoshioY
|
pubmed:issnType |
Electronic
|
pubmed:volume |
1139
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
63-9
|
pubmed:meshHeading |
pubmed-meshheading:18991850-Adult,
pubmed-meshheading:18991850-Amphetamine-Related Disorders,
pubmed-meshheading:18991850-Asian Continental Ancestry Group,
pubmed-meshheading:18991850-Female,
pubmed-meshheading:18991850-Genotype,
pubmed-meshheading:18991850-Glutamate-Cysteine Ligase,
pubmed-meshheading:18991850-Humans,
pubmed-meshheading:18991850-Linkage Disequilibrium,
pubmed-meshheading:18991850-Male,
pubmed-meshheading:18991850-Methamphetamine,
pubmed-meshheading:18991850-Middle Aged,
pubmed-meshheading:18991850-Polymorphism, Single Nucleotide,
pubmed-meshheading:18991850-Protein Subunits,
pubmed-meshheading:18991850-Psychoses, Substance-Induced,
pubmed-meshheading:18991850-Schizophrenia
|
pubmed:year |
2008
|
pubmed:articleTitle |
Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population.
|
pubmed:affiliation |
Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan. taroh@fujita-hu.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|